发明名称 ISOXAZOLE COMPOUND FOR CANCER TREATMENT
摘要 <p>PROBLEM TO BE SOLVED: To provide a medicine for treatment of bladder cancer, colon cancer, liver cancer, lung cancer, breast cancer, vaginal cancer, ovarian cancer, pancreas cancer, kidney cancer, stomach cancer, gastrointestinal cancer, prostate cancer, head and neck cancer, peritoneal cavity cancer, thyroid cancer, bone cancer, cerebral cancer, central nervous system cancer and/or hematologic cancer, and/or for treatment of myelodysplastic syndrome, systemic mastocytosis, von Hippel-Lindau syndrome, multicentric Castleman's disease and/or psoriasis.SOLUTION: In order for treatment of diseases and the like described in the above problems, 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholine-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide or a tautomer, pharmaceutically acceptable salt, hydrate or solvate thereof is used.</p>
申请公布号 JP2014156475(A) 申请公布日期 2014.08.28
申请号 JP20140095330 申请日期 2014.05.02
申请人 NOVARTIS AG 发明人 PATRICK CHENE;GARCIA-ECHEVERRIA CARLOS;MICHAEL RUGAARD JENSEN;CORNELIA QUADT;THOMAS RADIMERSKI;JOSEPH SCHOEPFER
分类号 A61K31/5377;A61P3/04;A61P17/06;A61P35/00;A61P35/02 主分类号 A61K31/5377
代理机构 代理人
主权项
地址
您可能感兴趣的专利